134 related articles for article (PubMed ID: 23025332)
1. Are gait and mobility measures responsive to change following botulinum toxin injections in adults with lower limb spasticity?
Chan J; Winter A; Palit M; Sturt R; Graaff Sd; Holland AE
Disabil Rehabil; 2013 Jun; 35(12):959-67. PubMed ID: 23025332
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal assessment of gait quality in children with bilateral cerebral palsy following repeated lower limb intramuscular Botulinum toxin-A injections.
Read FA; Boyd RN; Barber LA
Res Dev Disabil; 2017 Sep; 68():35-41. PubMed ID: 28735160
[TBL] [Abstract][Full Text] [Related]
3. The effect of botulinum toxin injections on gait control in spastic stroke patients presenting with a stiff-knee gait.
Bleyenheuft C; Cockx S; Caty G; Stoquart G; Lejeune T; Detrembleur C
Gait Posture; 2009 Aug; 30(2):168-72. PubMed ID: 19442523
[TBL] [Abstract][Full Text] [Related]
4. Effects of botulinum toxin A in ambulant adults with spastic cerebral palsy: a randomized double-blind placebo controlled-trial.
Maanum G; Jahnsen R; Stanghelle JK; Sandvik L; Keller A
J Rehabil Med; 2011 Mar; 43(4):338-47. PubMed ID: 21305227
[TBL] [Abstract][Full Text] [Related]
5. Walking assessment with instrumented insoles in patients with lower limb spasticity after botulinum toxin infiltration.
Béseler MR; Grao CM; Gil A; Martínez Lozano MD
Neurologia; 2012; 27(9):519-30. PubMed ID: 22088852
[TBL] [Abstract][Full Text] [Related]
6. Botulinum toxin type B in the spastic arm: a randomized, double-blind, placebo-controlled, preliminary study.
Gracies JM; Bayle N; Goldberg S; Simpson DM
Arch Phys Med Rehabil; 2014 Jul; 95(7):1303-11. PubMed ID: 24709034
[TBL] [Abstract][Full Text] [Related]
7. Meaningful improvement in walking performance after Botulinum neurotoxin A (BoNT-A) in chronic spastic patients.
Cioncoloni D; Taddei S; Bielli S; Annunziata P; Mazzocchio R
NeuroRehabilitation; 2014; 34(1):185-92. PubMed ID: 24284465
[TBL] [Abstract][Full Text] [Related]
8. Beyond speed: Gait changes after botulinum toxin injections in chronic stroke survivors (a systematic review).
Cofré Lizama LE; Khan F; Galea MP
Gait Posture; 2019 May; 70():389-396. PubMed ID: 30974394
[TBL] [Abstract][Full Text] [Related]
9. Chemodenervation with botulinum toxin for spasticity and dystonia. The effects on gait.
O'Brien CF
Adv Neurol; 2001; 87():265-9. PubMed ID: 11347231
[No Abstract] [Full Text] [Related]
10. Botulinum toxin type B for gait freezing in Parkinson's disease.
Fernandez HH; Lannon MC; Trieschmann ME; Friedman JH
Med Sci Monit; 2004 Jul; 10(7):CR282-4. PubMed ID: 15232500
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of spasticity with injections of botulinum toxin. Review of the literature].
Fève A; Decq P; Filipetti P; Kéravel Y
Neurochirurgie; 1998 Sep; 44(3):192-6. PubMed ID: 9827435
[TBL] [Abstract][Full Text] [Related]
12. Variability and predictability of functional efficacy of botulinum toxin injection in leg spastic muscles.
Rousseaux M; Compère S; Launay MJ; Kozlowski O
J Neurol Sci; 2005 May; 232(1-2):51-7. PubMed ID: 15850582
[TBL] [Abstract][Full Text] [Related]
13. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
Wissel J; Entner T
Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
[TBL] [Abstract][Full Text] [Related]
14. Effect of simultaneous botulinum toxin injections into several muscles on impairment, activity, participation, and quality of life among stroke patients presenting with a stiff knee gait.
Caty GD; Detrembleur C; Bleyenheuft C; Deltombe T; Lejeune TM
Stroke; 2008 Oct; 39(10):2803-8. PubMed ID: 18635841
[TBL] [Abstract][Full Text] [Related]
15. [Experiences with botulinum toxin injections against spasticity in children].
Ramstad K; Karstensen AB; Risberg K; Bergsaker DK; Sommer FF
Tidsskr Nor Laegeforen; 2006 Feb; 126(4):450-2. PubMed ID: 16477283
[TBL] [Abstract][Full Text] [Related]
16. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
Kaishou Xu ; Tiebin Yan ; Jianning Mai
Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
[TBL] [Abstract][Full Text] [Related]
17. Frequency and characteristics of goal attainment following BoNT-A injection for management of spasticity.
Mullins D; Winter A; Fini N; Dixon C; Aldous S; Palit M; Holland AE
Disabil Rehabil; 2016 Sep; 38(19):1927-33. PubMed ID: 26714558
[TBL] [Abstract][Full Text] [Related]
18. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after stroke.
Jahangir AW; Tan HJ; Norlinah MI; Nafisah WY; Ramesh S; Hamidon BB; Raymond AA
Med J Malaysia; 2007 Oct; 62(4):319-22. PubMed ID: 18551937
[TBL] [Abstract][Full Text] [Related]
19. [Spasticity and botulinum toxin in 2003. An update].
Fève A
Neurochirurgie; 2003 May; 49(2-3 Pt 2):265-70. PubMed ID: 12746701
[TBL] [Abstract][Full Text] [Related]
20. Physical and occupational therapy considerations in adult patients receiving botulinum toxin injections for spasticity.
Albany K
Muscle Nerve Suppl; 1997; 6():S221-31. PubMed ID: 9826993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
